Literature DB >> 20092997

Age- and brain region-specific effects of dietary vitamin K on myelin sulfatides.

Natalia A Crivello1, Sherley L Casseus, James W Peterson, Donald E Smith, Sarah L Booth.   

Abstract

Dysregulation of myelin sulfatides is a risk factor for cognitive decline with age. Vitamin K is present in high concentrations in the brain and has been implicated in the regulation of sulfatide metabolism. Our objective was to investigate the age-related interrelation between dietary vitamin K and sulfatides in myelin fractions isolated from the brain regions of Fischer 344 male rats fed one of two dietary forms of vitamin K: phylloquinone or its hydrogenated form, 2',3'-dihydrophylloquinone (dK), for 28 days. Both dietary forms of vitamin K were converted to menaquinone-4 (MK-4) in the brain. The efficiency of dietary dK conversion to MK-4 compared to dietary phylloquinone was lower in the striatum and cortex, and was similar to that in the hippocampus. There were significant positive correlations between sulfatides and MK-4 in the hippocampus (phylloquinone-supplemented diet, 12 and 24 months; dK-supplemented diet, 12 months) and cortex (phylloquinone-supplemented diet, 12 and 24 months). No significant correlations were observed in the striatum. Furthermore, sulfatides in the hippocampus were significantly positively correlated with MK-4 in serum. This is the first attempt to establish and characterize a novel animal model that exploits the inability of dietary dK to convert to brain MK-4 to study the dietary effects of vitamin K on brain sulfatide in brain regions controlling motor and cognitive functions. Our findings suggest that this animal model may be useful for investigation of the effect of the dietary vitamin K on sulfatide metabolism, myelin structure and behavior functions.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20092997      PMCID: PMC2891353          DOI: 10.1016/j.jnutbio.2009.09.005

Source DB:  PubMed          Journal:  J Nutr Biochem        ISSN: 0955-2863            Impact factor:   6.048


  45 in total

Review 1.  Exogenous lipids in myelination and myelination.

Authors:  A Di Biase; S Salvati
Journal:  Kaohsiung J Med Sci       Date:  1997-01       Impact factor: 2.744

2.  Phospholipid composition of myelin and synaptosomal proteolipid from vertebrate brain.

Authors:  N A Denisova
Journal:  Int J Biochem       Date:  1990

3.  Fatty acid composition of phospholipids of myelin and synaptosomal proteolipid complexes from vertebrate brain.

Authors:  N A Denisova; N V Gorbunov; N F Avrova
Journal:  Int J Biochem       Date:  1991

4.  Determination of phylloquinone in foods by high-performance liquid chromatography.

Authors:  S L Booth; J A Sadowski
Journal:  Methods Enzymol       Date:  1997       Impact factor: 1.600

Review 5.  Recent advances in myelin biochemistry.

Authors:  W T Norton
Journal:  Ann N Y Acad Sci       Date:  1984       Impact factor: 5.691

Review 6.  Neurobiological bases of age-related cognitive decline in the rhesus monkey.

Authors:  A Peters; D L Rosene; M B Moss; T L Kemper; C R Abraham; J Tigges; M S Albert
Journal:  J Neuropathol Exp Neurol       Date:  1996-08       Impact factor: 3.685

7.  Vitamin K status influences brain sulfatide metabolism in young mice and rats.

Authors:  K S Sundaram; J H Fan; J A Engelke; A L Foley; J W Suttie; M Lev
Journal:  J Nutr       Date:  1996-11       Impact factor: 4.798

8.  High-pressure freezing and freeze-substitution of native rat brain: suitability for preservation and immunoelectron microscopic localization of myelin glycolipids.

Authors:  E Kirschning; G Rutter; H Hohenberg
Journal:  J Neurosci Res       Date:  1998-08-15       Impact factor: 4.164

9.  Elevated cerebrospinal fluid sulfatide concentrations as a sign of increased metabolic turnover of myelin in HIV type I infection.

Authors:  M Gisslén; P Fredman; G Norkrans; L Hagberg
Journal:  AIDS Res Hum Retroviruses       Date:  1996-01-20       Impact factor: 2.205

10.  Membrane lipids, selectively diminished in Alzheimer brains, suggest synapse loss as a primary event in early-onset form (type I) and demyelination in late-onset form (type II).

Authors:  L Svennerholm; C G Gottfries
Journal:  J Neurochem       Date:  1994-03       Impact factor: 5.372

View more
  7 in total

Review 1.  The emerging threat of superwarfarins: history, detection, mechanisms, and countermeasures.

Authors:  Douglas L Feinstein; Belinda S Akpa; Manuela A Ayee; Anne I Boullerne; David Braun; Sergey V Brodsky; David Gidalevitz; Zane Hauck; Sergey Kalinin; Kathy Kowal; Ivan Kuzmenko; Kinga Lis; Natalia Marangoni; Michael W Martynowycz; Israel Rubinstein; Richard van Breemen; Kyle Ware; Guy Weinberg
Journal:  Ann N Y Acad Sci       Date:  2016-05-31       Impact factor: 5.691

Review 2.  Vitamin K and the nervous system: an overview of its actions.

Authors:  Guylaine Ferland
Journal:  Adv Nutr       Date:  2012-03-01       Impact factor: 8.701

Review 3.  Vitamin Supplementation as an Adjuvant Treatment for Alzheimer's Disease.

Authors:  Adnan Bashir Bhatti; Muhammad Usman; Farhan Ali; Siddique Akbar Satti
Journal:  J Clin Diagn Res       Date:  2016-08-01

Review 4.  The Role of 3-O-Sulfogalactosylceramide, Sulfatide, in the Lateral Organization of Myelin Membrane.

Authors:  Sara Grassi; Simona Prioni; Livia Cabitta; Massimo Aureli; Sandro Sonnino; Alessandro Prinetti
Journal:  Neurochem Res       Date:  2015-11-05       Impact factor: 3.996

Review 5.  The challenge of understanding cerebral white matter injury in the premature infant.

Authors:  C M Elitt; P A Rosenberg
Journal:  Neuroscience       Date:  2014-05-15       Impact factor: 3.590

6.  Vitamin K2 in multiple sclerosis patients.

Authors:  Reza Lasemi; Michael Kundi; Nahid Beladi Moghadam; Hanns Moshammer; Johannes A Hainfellner
Journal:  Wien Klin Wochenschr       Date:  2018-03-02       Impact factor: 1.704

7.  Vitamin K enhances the production of brain sulfatides during remyelination.

Authors:  Daniela C Popescu; He Huang; Naveen K Singhal; Leah Shriver; Jennifer McDonough; Robert J Clements; Ernest J Freeman
Journal:  PLoS One       Date:  2018-08-27       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.